SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-222392
Filing Date
2012-05-09
Accepted
2012-05-09 17:09:31
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d316297d10ka.htm 10-K/A 59623
2 COLLABORATION AGREEMENT d316297dex108.htm EX-10.8 324069
3 LICENSE AGREEMENT d316297dex109.htm EX-10.9 184917
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 d316297dex311.htm EX-31.1 10017
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 d316297dex312.htm EX-31.2 9880
6 CERTIFICATIONS OF THE CEO AND THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 d316297dex321.htm EX-32.1 4647
7 GRAPHIC g316297g97p92.jpg GRAPHIC 25819
  Complete submission text file 0001193125-12-222392.txt   629908
Mailing Address 2211 BRIDGEPOINTE PARKWAY SUITE 500 SAN MATEO CA 94404
Business Address 2211 BRIDGEPOINTE PARKWAY SUITE 500 SAN MATEO CA 94404 6506248200
PAIN THERAPEUTICS INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-29959 | Film No.: 12826648
SIC: 2834 Pharmaceutical Preparations